• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-39 是一种与 2 型糖尿病相关的新型细胞因子,与体重指数呈正相关。

Interleukin-39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index.

机构信息

Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq.

Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq.

出版信息

Endocrinol Diabetes Metab. 2023 May;6(3):e409. doi: 10.1002/edm2.409. Epub 2023 Feb 9.

DOI:10.1002/edm2.409
PMID:36757903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10164431/
Abstract

INTRODUCTION

It is suggested that cytokines play a key role in the pathogenesis of type 2 diabetes mellitus (T2DM). Therefore, this study explored two recently discovered cytokines, interleukin (IL)-37 (anti-inflammatory) and IL-39 (pro-inflammatory), in T2DM due to limited data in this context.

METHODS

Serum IL-37 and IL-39 levels were determined in 106 T2DM patients and 109 controls using enzyme-linked immunosorbent assay kits.

RESULTS

Serum levels (median and interquartile range) of IL-37 (79 [47-102] vs. 60 [46-89] ng/L; probability [p] = .04) and IL-39 (66 [59-69] vs. 31 [19-42] ng/L; p < .001) were significantly elevated in T2DM patients compared to controls. As indicated by the area under the curve (AUC), IL-39 (AUC = 0.973; p < .001) was more predictable for T2DM than IL-37 (AUC = 0.582; p = .039). Elevated levels of IL-39 were significantly associated with T2DM (odds ratio = 1.30; p < .001), while IL-37 did not show this association. Classification of IL-37 and IL-39 levels by demographic and clinical characteristics of patients revealed some significant differences including gender (IL-39), body mass index (BMI; IL-37 and IL-39) and diabetic neuropathy (IL-39). BMI was positively correlated with IL-39 (correlation coefficient [r ] = 0.27; p = .005) and glycosylated haemoglobin (r  = 0.31; p = .001), and negatively correlated with age at onset (r  = -0.24; p = .015).

CONCLUSIONS

IL-37 and IL-39 levels were elevated in the serum of T2DM patients. Besides, IL-39 is proposed to be a novel cytokine associated with T2DM and positively correlated with BMI.

摘要

简介

有观点认为细胞因子在 2 型糖尿病(T2DM)的发病机制中起着关键作用。因此,由于这方面的数据有限,本研究探索了两种最近发现的细胞因子,白细胞介素(IL)-37(抗炎)和 IL-39(促炎),在 T2DM 中的作用。

方法

采用酶联免疫吸附试验试剂盒检测 106 例 T2DM 患者和 109 例对照者血清 IL-37 和 IL-39 水平。

结果

与对照组相比,T2DM 患者血清 IL-37(中位数[四分位距]:79[47-102]比 60[46-89]ng/L;概率[p] =.04)和 IL-39(66[59-69]比 31[19-42]ng/L;p<.001)水平显著升高。曲线下面积(AUC)表明,IL-39(AUC=0.973;p<.001)对 T2DM 的预测作用优于 IL-37(AUC=0.582;p=0.039)。IL-39 水平升高与 T2DM 显著相关(比值比[OR]=1.30;p<.001),而 IL-37 则没有这种相关性。根据患者的人口统计学和临床特征对 IL-37 和 IL-39 水平进行分类,发现了一些显著差异,包括性别(IL-39)、体重指数(BMI;IL-37 和 IL-39)和糖尿病神经病变(IL-39)。BMI 与 IL-39 呈正相关(相关系数[r]=0.27;p=0.005)和糖化血红蛋白(r=0.31;p=0.001),与发病年龄呈负相关(r=-0.24;p=0.015)。

结论

T2DM 患者血清中 IL-37 和 IL-39 水平升高。此外,IL-39 被认为是一种与 T2DM 相关的新型细胞因子,与 BMI 呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/39db67d01e61/EDM2-6-e409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/ea0d89042939/EDM2-6-e409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/3ced74200e58/EDM2-6-e409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/39db67d01e61/EDM2-6-e409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/ea0d89042939/EDM2-6-e409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/3ced74200e58/EDM2-6-e409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79ec/10164431/39db67d01e61/EDM2-6-e409-g004.jpg

相似文献

1
Interleukin-39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index.白细胞介素-39 是一种与 2 型糖尿病相关的新型细胞因子,与体重指数呈正相关。
Endocrinol Diabetes Metab. 2023 May;6(3):e409. doi: 10.1002/edm2.409. Epub 2023 Feb 9.
2
Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.白细胞介素-40是一种与2型糖尿病风险相关的有前景的生物标志物。
Immunol Lett. 2023 Feb;254:1-5. doi: 10.1016/j.imlet.2023.01.006. Epub 2023 Jan 11.
3
The correlation between testosterone, inflammation and cytokine status in type-2 diabetes men.2 型糖尿病男性的睾酮、炎症和细胞因子状态之间的相关性。
Andrologia. 2022 Nov;54(10):e14526. doi: 10.1111/and.14526. Epub 2022 Jul 7.
4
Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients.血清蛋白酶激活受体 (PAR-1) 水平作为 2 型糖尿病患者炎症诊断的潜在生物标志物。
Inflammopharmacology. 2022 Oct;30(5):1843-1851. doi: 10.1007/s10787-022-01049-0. Epub 2022 Aug 16.
5
Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.中国2型糖尿病患者血清内脂素水平降低,且与体重指数呈负相关。
Endocr J. 2018 Jul 28;65(7):685-691. doi: 10.1507/endocrj.EJ18-0060. Epub 2018 Apr 17.
6
Role of interleukin-2 and interleukin-18 in newly diagnosed type 2 diabetes mellitus.白细胞介素-2 和白细胞介素-18 在新诊断 2 型糖尿病中的作用。
J Basic Clin Physiol Pharmacol. 2021 Mar 15;33(2):185-190. doi: 10.1515/jbcpp-2020-0272.
7
NF-kappaB binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population.NF-κB 结合活性和促炎细胞因子的表达与体重指数相关,但与中国人群的糖化血红蛋白无关。
Diabetes Res Clin Pract. 2010 Oct;90(1):73-80. doi: 10.1016/j.diabres.2010.06.016. Epub 2010 Jul 14.
8
Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.血清白细胞介素-32 水平在 2 型糖尿病患者中的变化及其与肿瘤坏死因子-α和白细胞介素-6 的关系。
Cytokine. 2020 Jan;125:154832. doi: 10.1016/j.cyto.2019.154832. Epub 2019 Aug 31.
9
A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis.白细胞介素 36α、37、38、39 和 40 的新型标志物在强直性脊柱炎中的研究。
Cytokine. 2023 Feb;162:156117. doi: 10.1016/j.cyto.2022.156117. Epub 2022 Dec 29.
10
Serum IL-36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation.2 型糖尿病患者血清 IL-36 细胞因子水平及其与肥胖、胰岛素抵抗和炎症的关系。
J Clin Lab Anal. 2021 Feb;35(2):e23611. doi: 10.1002/jcla.23611. Epub 2020 Oct 9.

引用本文的文献

1
Evolutionary insights into Interleukin-12 family targets across 405 species.对405个物种白细胞介素-12家族靶点的进化见解。
Front Immunol. 2025 May 30;16:1584460. doi: 10.3389/fimmu.2025.1584460. eCollection 2025.
2
Interleukin -39 Expression in Pleural Effusion and Its Diagnostic Value for Tuberculous Pleurisy.白细胞介素-39在胸腔积液中的表达及其对结核性胸膜炎的诊断价值
J Inflamm Res. 2025 Apr 5;18:4755-4770. doi: 10.2147/JIR.S488017. eCollection 2025.
3
The significant role of IL-15, IL-22, IL-37, and caspase 9 in polycystic ovary syndrome: A case-control study in a sample of Iraqi women.

本文引用的文献

1
Obesity: A Chronic Low-Grade Inflammation and Its Markers.肥胖:一种慢性低度炎症及其标志物。
Cureus. 2022 Feb 28;14(2):e22711. doi: 10.7759/cureus.22711. eCollection 2022 Feb.
2
The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection.雌激素及其受体在感染期间对免疫和炎症的影响。
Cancers (Basel). 2022 Feb 12;14(4):909. doi: 10.3390/cancers14040909.
3
Low levels of serum IL-39 are associated with autoimmune thyroid disease.血清 IL-39 水平低与自身免疫性甲状腺疾病有关。
白细胞介素-15、白细胞介素-22、白细胞介素-37和半胱天冬酶9在多囊卵巢综合征中的重要作用:一项针对伊拉克女性样本的病例对照研究。
J Genet Eng Biotechnol. 2025 Mar;23(1):100462. doi: 10.1016/j.jgeb.2025.100462. Epub 2025 Feb 1.
4
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.免疫系统的代谢调控在健康和疾病中的作用:机制与干预措施。
Signal Transduct Target Ther. 2024 Oct 9;9(1):268. doi: 10.1038/s41392-024-01954-6.
5
IL-39 and IL-35 gingival crevicular fluid levels in diabetic patients with generalized periodontitis.白细胞介素 39 和白细胞介素 35 在患有广泛性牙周炎的糖尿病患者的龈沟液中的水平。
Clin Oral Investig. 2024 Jan 30;28(2):124. doi: 10.1007/s00784-023-05484-3.
6
VDR downregulation and promoter hypermethylation as one of the causes for triggering type 2 diabetes mellitus: Clinical and molecular studies.维生素D受体下调和启动子高甲基化作为引发2型糖尿病的原因之一:临床与分子研究
J Diabetes Metab Disord. 2023 Jul 29;22(2):1443-1451. doi: 10.1007/s40200-023-01266-6. eCollection 2023 Dec.
J Clin Lab Anal. 2022 Apr;36(4):e24284. doi: 10.1002/jcla.24284. Epub 2022 Feb 19.
4
Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus.白细胞介素-37:新冠病毒、糖尿病与黑真菌之间的联系。
Front Microbiol. 2022 Jan 13;12:788741. doi: 10.3389/fmicb.2021.788741. eCollection 2021.
5
Why does obesity cause diabetes?肥胖为什么会导致糖尿病?
Cell Metab. 2022 Jan 4;34(1):11-20. doi: 10.1016/j.cmet.2021.12.012.
6
Obesity and Diabetes.肥胖与糖尿病。
Nurs Clin North Am. 2021 Dec;56(4):527-541. doi: 10.1016/j.cnur.2021.07.008.
7
Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control.靶向炎症细胞因子以改善 2 型糖尿病控制。
Biomed Res Int. 2021 Sep 13;2021:7297419. doi: 10.1155/2021/7297419. eCollection 2021.
8
The Role of IL-37 and IL-38 in Obstetrics Abnormalities.白细胞介素-37和白细胞介素-38在产科异常中的作用
Front Med (Lausanne). 2021 Aug 27;8:737084. doi: 10.3389/fmed.2021.737084. eCollection 2021.
9
Current Understanding of IL-37 in Human Health and Disease.IL-37 在人类健康和疾病中的现有认识。
Front Immunol. 2021 Jun 25;12:696605. doi: 10.3389/fimmu.2021.696605. eCollection 2021.
10
Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease.白细胞介素-39 通过白细胞介素-23 受体信号转导增强急性移植物抗宿主病中的 T 细胞致病性。
Am J Transplant. 2021 Nov;21(11):3538-3549. doi: 10.1111/ajt.16624. Epub 2021 Jun 1.